3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
3
Phase 2
1
Status
Completed
10
Terminated
3
Withdrawn
1
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
309
Carcinoma, Non-Small-Cell Lung
281
Prostatic Neoplasms
160
Colorectal Neoplasms
155
Carcinoma, Hepatocellular
144
Neoplasms
134
Leukemia, Myeloid, Acute
132
Lung Neoplasms
115
Squamous Cell Carcinoma of Head and Neck
108
Multiple Myeloma
103
Triple Negative Breast Neoplasms
102
Recurrence
99
Pancreatic Neoplasms
93
Stomach Neoplasms
92
Ovarian Neoplasms
87
Neoplasm Metastasis
87
Lymphoma, Large B-Cell, Diffuse
81
Sarcoma
70
Precursor Cell Lymphoblastic Leukemia-Lymphoma
67
Esophageal Neoplasms
67
Uterine Cervical Neoplasms
66
Melanoma
65
Brain Neoplasms
65
Rectal Neoplasms
62
Head and Neck Neoplasms
62
Glioblastoma
60
Carcinoma, Renal Cell
57
Myelodysplastic Syndromes
55
Lymphoma
55
Esophageal Squamous Cell Carcinoma
54
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Recruiting
×
Monoclonal Gammopathy of Undetermined Significance
×
Clear all
NCT06140524
2026-06-04
LINKER-MGUS1
Regeneron Pharmaceuticals
Phase 2
Recruiting
116 enrolled